Untch, M., Jackisch, C., Schneeweiss, A., Conrad, B., Aktaş, B., Denkert, C., . . . Minckwitz, G. v. (2016). Nab-paclitaxel versus solvent-based paclitaxel in neoadjuvant chemotherapy for early breast cancer (GeparSepto-GBG 69): A randomised, phase 3 trial. The lancet <London> / Oncology, 17(3), .
Chicago-Zitierstil (17. Ausg.)Untch, Michael, et al. "Nab-paclitaxel Versus Solvent-based Paclitaxel in Neoadjuvant Chemotherapy for Early Breast Cancer (GeparSepto-GBG 69): A Randomised, Phase 3 Trial." The Lancet <London> / Oncology 17, no. 3 (2016).
MLA-Zitierstil (9. Ausg.)Untch, Michael, et al. "Nab-paclitaxel Versus Solvent-based Paclitaxel in Neoadjuvant Chemotherapy for Early Breast Cancer (GeparSepto-GBG 69): A Randomised, Phase 3 Trial." The Lancet <London> / Oncology, vol. 17, no. 3, 2016.